{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:50:34Z","timestamp":1790239834409,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.critrevonc.2021.103496","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T15:38:22Z","timestamp":1634139502000},"page":"103496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas"],"prefix":"10.1016","volume":"167","author":[{"given":"Natalia","family":"Zing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.critrevonc.2021.103496_bib0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1346-8138.2010.01120.x","article-title":"Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia\u200a\/\u200alymphoma","volume":"38","author":"Amano","year":"2011","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103496_bib0010","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.3324\/haematol.2019.218305","article-title":"The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project","volume":"104","author":"Bellei","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1309\/2YGD1P0QCVCWBLDX","article-title":"Adult T-cell leukemia\/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients","volume":"128","author":"Bittencourt","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0020","first-page":"5","article-title":"Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas","volume":"106","author":"Bobillo","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103496_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.57.3.393","article-title":"MRI features of primary central nervous system lymphomas at presentation","volume":"57","author":"B\u00fchring","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3109\/09273948.2016.1139733","article-title":"Intraocular T-cell lymphoma: clinical presentation, diagnosis, treatment, and outcome","volume":"25","author":"Chaput","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.critrevonc.2021.103496_bib0035","doi-asserted-by":"crossref","first-page":"3606970","DOI":"10.1155\/2018\/3606970","article-title":"Primary CNS lymphomas: challenges in diagnosis and monitoring","volume":"2018","author":"Chiavazza","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11899-018-0431-4","article-title":"Central nervous system involvement in peripheral t cell lymphoma","volume":"13","author":"Chihara","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103496_bib0045","doi-asserted-by":"crossref","first-page":"e0191461","DOI":"10.1371\/journal.pone.0191461","article-title":"The risk of central nervous system relapses in patients with peripheral T-cell lymphoma","volume":"13","author":"Chihara","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0050","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-019-49784-9","article-title":"Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-\u03b2 probes","volume":"9","author":"Choi","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2021.103496_bib0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-Cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2021.103496_bib0060","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2010.34.1313","article-title":"CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib","volume":"29","author":"Costa","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood-2014-12-616961","article-title":"Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study","volume":"126","author":"Ellin","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.critrevonc.2021.103496_bib0070","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1182\/blood-2015-10-636340","article-title":"The role of autologous stem cell transplantation in primary central nervous system lymphoma","volume":"127","author":"Ferreri","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bjh.13194","article-title":"Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"168","author":"Ferreri","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103496_bib0080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/EDBK_242547","article-title":"Evolving treatments for primary central nervous system lymphoma","volume":"39","author":"Ferreri","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103496_bib0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.2019000633","article-title":"R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-\u03b1 in primary CNS lymphoma","volume":"134","author":"Ferreri","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103496_bib0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12185-011-0935-3","article-title":"Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience","volume":"94","author":"Fukushima","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.survophthal.2018.10.003","article-title":"Primary vitreoretinal natural killer\/T-cell lymphoma with breast involvement: a case report and review of the literature","volume":"64","author":"Gao","year":"2019","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4274\/Tjh.2012.0028","article-title":"Central nervous system involvement of T-cell prolymphocytic leukemia diagnosed with stereotactic brain biopsy: case report","volume":"31","author":"G\u00f6\u00e7men","year":"2014","journal-title":"Turk. J. Haematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/0284186X.2015.1118656","article-title":"Central nervous system involvement in T-cell lymphoma: a single center experience","volume":"55","author":"Gurion","year":"2016","journal-title":"Acta Oncol. (Madr)"},{"issue":"9","key":"10.1016\/j.critrevonc.2021.103496_bib0110","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1080\/10428190410001697368","article-title":"Primary omental gamma\/delta T-cell lymphoma involving the central nervous system","volume":"45","author":"Harada","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12885-019-5394-x","article-title":"Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas","volume":"19","author":"Hickmann","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0120","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology","volume":"16","author":"Hoang-Xuan","year":"2015","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/annonc\/mds621","article-title":"Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell\/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study","volume":"24","author":"Holte","year":"2013","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/PAS.0000000000000109","article-title":"Clinicopathologic features of adult T-cell leukemias\/lymphomas at a North American tertiary care medical center: infrequent involvement of the central nervous system","volume":"38","author":"Hsi","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103496_bib0135","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1159\/000495033","article-title":"Central nervous system peripheral t cell lymphoma manifesting as lymphomatosis cerebri that was misdiagnosed as Neuro-Beh\u00e7et\u2019s disease: a case report","volume":"11","author":"Imataki","year":"2018","journal-title":"Case Rep. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4143\/crt.2007.39.1.40","article-title":"Orbital infiltration as the first site of relapse of primary testicular T-cell lymphoma","volume":"39","author":"Jun","year":"2007","journal-title":"Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0145","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/annonc\/mdp412","article-title":"When do we need central nervous system prophylaxis in patients with extranodal NK\/T-cell lymphoma, nasal type?","volume":"21","author":"Kim","year":"2010","journal-title":"Ann. Oncol."},{"issue":"22","key":"10.1016\/j.critrevonc.2021.103496_bib0150","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.2020005026","article-title":"Prediction and prevention of central nervous system relapse in patients with extranodal natural killer\/T-cell lymphoma","volume":"136","author":"Kim","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00234-002-0787-x","article-title":"Central nervous system lesions in adult T-cell leukaemia: MRI and pathology","volume":"44","author":"Kitajima","year":"2002","journal-title":"Neuroradiology"},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103496_bib0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.2012.077917","article-title":"Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas","volume":"98","author":"Korfel","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-004-3390-7","article-title":"Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients","volume":"72","author":"K\u00fcker","year":"2005","journal-title":"J. Neurooncol."},{"issue":"17","key":"10.1016\/j.critrevonc.2021.103496_bib0175","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2021.103496_bib0180","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/bloodadvances.2020001518","article-title":"Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis","volume":"4","author":"Lepp\u00e4","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11060-008-9633-2","article-title":"Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis","volume":"90","author":"Levin","year":"2008","journal-title":"J. Neurooncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0190","first-page":"1463","article-title":"Neuroradiological features of lymphomatosis cerebri: a systematic review of the English literature with a new case report","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.critrevonc.2021.103496_bib0195","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00277-011-1225-0","article-title":"Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes","volume":"90","author":"Lim","year":"2011","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0200","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00000478-200305000-00012","article-title":"Primary central nervous system cytotoxic\/suppressor T-cell lymphoma: report of a unique case and review of the literature","volume":"27","author":"Liu","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103496_bib0205","first-page":"917369","article-title":"Adult T-cell lymphoma\/leukemia presenting as isolated central nervous system T-cell lymphoma","volume":"2014","author":"Ma","year":"2014","journal-title":"Case Rep. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-510X(98)00111-7","article-title":"HTLV-I associated primary CNS T-cell lymphoma","volume":"158","author":"Marshall","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103496_bib0215","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00415-015-7713-8","article-title":"Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study","volume":"262","author":"Matinella","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjh.12509","article-title":"Guideline on the prevention of secondary central nervous system lymphoma: british Committee for Standards in Haematology","volume":"163","author":"McMillan","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2021.103496_bib0225","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","article-title":"Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis","volume":"39","author":"Menon","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/his.13223","article-title":"Clinicopathological analysis of primary central nervous system NK\/T cell lymphoma: rare and localized aggressive tumour among extranasal NK\/T cell tumours","volume":"71","author":"Miyata-Takata","year":"2017","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0235","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/10428194.2018.1551541","article-title":"Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer\/T-cell lymphoma","volume":"60","author":"Nevel","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103496_bib0240","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/neup.12005","article-title":"Epstein-Barr virus-associated primary central nervous system cytotoxic T-cell lymphoma","volume":"33","author":"Ogura","year":"2013","journal-title":"Neuropathology"},{"issue":"11","key":"10.1016\/j.critrevonc.2021.103496_bib0245","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/annonc\/mdf300","article-title":"Primary brain CD30+ ALK1+ anaplastic large cell lymphoma (\u2019ALKoma\u2019): the first case with a combination of\u2019 not common\u2019 variants","volume":"13","author":"Ponzoni","year":"2002","journal-title":"Ann. Oncol."},{"issue":"26","key":"10.1016\/j.critrevonc.2021.103496_bib0250","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1182\/blood-2010-02-266890","article-title":"Central nervous system prophylaxis in peripheral T-cell lymphoma","volume":"115","author":"Pro","year":"2010","journal-title":"Blood"},{"issue":"4 Suppl 2","key":"10.1016\/j.critrevonc.2021.103496_bib0255","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous system disease in hematologic malignancies: historical perspective and practical applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-019-0692-8","article-title":"Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis","volume":"7","author":"Rimelen","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2021.103496_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10428190802311441","article-title":"Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment","volume":"49","author":"Rubenstein","year":"2008","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103496_bib0270","doi-asserted-by":"crossref","first-page":"e27003","DOI":"10.1002\/pbc.27003","article-title":"CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: a case series","volume":"65","author":"Ruf","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"18","key":"10.1016\/j.critrevonc.2021.103496_bib0275","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0280","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1021\/cn500021p","article-title":"Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors","volume":"5","author":"Seo","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/02688697.2013.817531","article-title":"Diagnosis of primary cerebral lymphomas: possible value of PCR testing in equivocal cases requiring rebiopsy","volume":"28","author":"Shaw","year":"2014","journal-title":"Br. J. Neurosurg."},{"issue":"10","key":"10.1016\/j.critrevonc.2021.103496_bib0290","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2005.07.109","article-title":"Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group","volume":"23","author":"Shenkier","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2021.103496_bib0295","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00130404-200601000-00010","article-title":"Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors","volume":"12","author":"Stein","year":"2006","journal-title":"Cancer J."},{"issue":"20","key":"10.1016\/j.critrevonc.2021.103496_bib0305","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W","article-title":"Central nervous system involvement in adult T-cell leukemia\/lymphoma","volume":"65","author":"Teshima","year":"1990","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103496_bib0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","article-title":"Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/lymphoma","volume":"17","author":"Tsukasaki","year":"1993","journal-title":"Leuk. Res."},{"issue":"34","key":"10.1016\/j.critrevonc.2021.103496_bib0320","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: japan clinical oncology group study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.critrevonc.2021.103496_bib0325","first-page":"e12028","article-title":"Extranodal natural killer\/T cell lymphoma, nasal type in the middle cranial fossa: a case report","volume":"97","author":"Wang","year":"2018","journal-title":"Bull. Sch. Med. Md"},{"issue":"15","key":"10.1016\/j.critrevonc.2021.103496_bib0330","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1182\/bloodadvances.2020002421","article-title":"Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery","volume":"4","author":"Wilson","year":"2020","journal-title":"Blood Adv."},{"issue":"33","key":"10.1016\/j.critrevonc.2021.103496_bib0335","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0340","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00277-019-03689-9","article-title":"Improved prognosis of extranodal NK\/T cell lymphoma, nasal type of nasal origin but not extranasal origin","volume":"98","author":"Yamaguchi","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103496_bib0345","first-page":"14","article-title":"Thinking about CNS metastasis in cutaneous lymphoma: analysis of existing data","volume":"8","author":"Yang","year":"2017","journal-title":"Leuk. Res. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2021.103496_bib0350","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/annonc\/mdq645","article-title":"Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma","volume":"22","author":"Yi","year":"2011","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2021.103496_bib0355","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00277-019-03791-y","article-title":"Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"98","author":"Yi","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103496_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lungcan.2016.04.006","article-title":"Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer","volume":"97","author":"Yoshida","year":"2016","journal-title":"Lung Cancer."},{"issue":"19","key":"10.1016\/j.critrevonc.2021.103496_bib0365","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"Younes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103496_bib0370","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.clml.2013.09.016","article-title":"Central nervous system involvement in cutaneous T-cell lymphoma: 2 illustrative cases and a review of current literature","volume":"14","author":"Zhao","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"8","key":"10.1016\/j.critrevonc.2021.103496_bib0375","article-title":"Peripheral T-Cell lymphomas: incorporating new developments in diagnostics, prognostication, and treatment into clinical Practice-PART 2: ENKTL, EATL, indolent T-Cell LDP of the GI tract, ATLL, and hepatosplenic T-Cell lymphoma","volume":"32","author":"Zing","year":"2018","journal-title":"Oncology (Williston Park, N.Y.)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:40:08Z","timestamp":1760902808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821002833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":75,"alternative-id":["S1040842821002833"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103496","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103496"}}